Clinical Trials Browser

Phase 1/2 × Small Cell Lung Carcinoma × pelcitoclax × Clear all

NCT04210037 2022-07-12

Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer

Phase 1/2 Terminated

Small Cell Lung Carcinoma